| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pyruvic Acid | 20 | 2024 | 133 | 8.120 |
Why?
|
| Magnetic Resonance Imaging | 62 | 2024 | 7925 | 4.120 |
Why?
|
| Magnetic Resonance Spectroscopy | 12 | 2023 | 609 | 3.160 |
Why?
|
| Carbon Isotopes | 13 | 2024 | 364 | 3.040 |
Why?
|
| Phantoms, Imaging | 18 | 2022 | 1330 | 1.860 |
Why?
|
| Lactic Acid | 9 | 2023 | 312 | 1.470 |
Why?
|
| Contrast Media | 21 | 2022 | 1506 | 1.420 |
Why?
|
| Image Processing, Computer-Assisted | 17 | 2024 | 1701 | 1.280 |
Why?
|
| Echo-Planar Imaging | 3 | 2021 | 74 | 1.180 |
Why?
|
| Image Enhancement | 6 | 2015 | 555 | 0.980 |
Why?
|
| Transducers | 3 | 2012 | 59 | 0.840 |
Why?
|
| Heart | 8 | 2024 | 1201 | 0.810 |
Why?
|
| Carbon-13 Magnetic Resonance Spectroscopy | 3 | 2019 | 13 | 0.790 |
Why?
|
| Mice | 60 | 2024 | 36023 | 0.780 |
Why?
|
| Mice, Nude | 29 | 2021 | 4359 | 0.730 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2019 | 209 | 0.730 |
Why?
|
| Whole Body Imaging | 2 | 2012 | 114 | 0.720 |
Why?
|
| Prostatic Neoplasms | 8 | 2022 | 5995 | 0.690 |
Why?
|
| Computer Simulation | 8 | 2023 | 1572 | 0.680 |
Why?
|
| Reproducibility of Results | 15 | 2021 | 6203 | 0.660 |
Why?
|
| Animals | 74 | 2024 | 62782 | 0.600 |
Why?
|
| Gadolinium | 6 | 2022 | 170 | 0.590 |
Why?
|
| Head and Neck Neoplasms | 7 | 2024 | 4138 | 0.570 |
Why?
|
| Equipment Design | 9 | 2015 | 1206 | 0.540 |
Why?
|
| Fluorine-19 Magnetic Resonance Imaging | 1 | 2016 | 6 | 0.530 |
Why?
|
| Thyroid Neoplasms | 7 | 2016 | 1884 | 0.530 |
Why?
|
| Algorithms | 10 | 2021 | 3926 | 0.520 |
Why?
|
| Magnetics | 4 | 2010 | 99 | 0.520 |
Why?
|
| Carbon Radioisotopes | 1 | 2015 | 125 | 0.510 |
Why?
|
| Metabolism | 1 | 2015 | 50 | 0.510 |
Why?
|
| Killer Cells, Natural | 2 | 2019 | 967 | 0.460 |
Why?
|
| Radiopharmaceuticals | 4 | 2017 | 1338 | 0.460 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2013 | 42 | 0.460 |
Why?
|
| Feasibility Studies | 9 | 2021 | 2357 | 0.450 |
Why?
|
| Signal-To-Noise Ratio | 3 | 2021 | 127 | 0.430 |
Why?
|
| Cell Line, Tumor | 29 | 2023 | 14882 | 0.400 |
Why?
|
| Neoplasms | 8 | 2021 | 15913 | 0.380 |
Why?
|
| Blood Vessels | 2 | 2020 | 235 | 0.370 |
Why?
|
| Gold | 5 | 2022 | 267 | 0.370 |
Why?
|
| Gadolinium DTPA | 6 | 2012 | 173 | 0.350 |
Why?
|
| Energy Metabolism | 2 | 2016 | 1004 | 0.330 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2019 | 158 | 0.330 |
Why?
|
| Adipose Tissue | 3 | 2010 | 735 | 0.320 |
Why?
|
| Xenograft Model Antitumor Assays | 12 | 2021 | 3930 | 0.320 |
Why?
|
| Liver | 4 | 2024 | 3127 | 0.310 |
Why?
|
| Disease Models, Animal | 13 | 2024 | 7474 | 0.310 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2021 | 316 | 0.290 |
Why?
|
| Kinetics | 4 | 2019 | 2242 | 0.280 |
Why?
|
| Brain Neoplasms | 6 | 2019 | 4992 | 0.270 |
Why?
|
| Colonic Neoplasms | 1 | 2014 | 1442 | 0.260 |
Why?
|
| Humans | 58 | 2024 | 271967 | 0.260 |
Why?
|
| Metal Nanoparticles | 2 | 2018 | 160 | 0.260 |
Why?
|
| Drug Monitoring | 2 | 2019 | 355 | 0.260 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2016 | 1839 | 0.260 |
Why?
|
| Models, Biological | 5 | 2019 | 3221 | 0.260 |
Why?
|
| Sensitivity and Specificity | 7 | 2017 | 5193 | 0.260 |
Why?
|
| Thoracic Neoplasms | 1 | 2008 | 349 | 0.240 |
Why?
|
| Tissue Distribution | 3 | 2016 | 946 | 0.240 |
Why?
|
| Artifacts | 3 | 2020 | 536 | 0.240 |
Why?
|
| Oxidation-Reduction | 2 | 2024 | 718 | 0.230 |
Why?
|
| Hot Temperature | 1 | 2005 | 289 | 0.230 |
Why?
|
| Brain | 6 | 2020 | 4237 | 0.230 |
Why?
|
| Multimodal Imaging | 3 | 2017 | 552 | 0.210 |
Why?
|
| Lactates | 1 | 2022 | 123 | 0.210 |
Why?
|
| Fatty Liver | 1 | 2024 | 257 | 0.200 |
Why?
|
| Nanoshells | 1 | 2022 | 43 | 0.200 |
Why?
|
| Models, Theoretical | 2 | 2017 | 808 | 0.200 |
Why?
|
| Biomarkers, Tumor | 4 | 2018 | 10756 | 0.200 |
Why?
|
| Equipment Failure Analysis | 3 | 2012 | 327 | 0.190 |
Why?
|
| Male | 25 | 2024 | 129048 | 0.190 |
Why?
|
| Prostate | 2 | 2020 | 1137 | 0.190 |
Why?
|
| Information Theory | 1 | 2020 | 9 | 0.190 |
Why?
|
| Lipid Metabolism | 1 | 2024 | 498 | 0.190 |
Why?
|
| Neoplasm Transplantation | 4 | 2014 | 1565 | 0.180 |
Why?
|
| Hyperthermia, Induced | 5 | 2005 | 511 | 0.180 |
Why?
|
| Mandibular Diseases | 1 | 2020 | 49 | 0.180 |
Why?
|
| Mustard Compounds | 2 | 2010 | 9 | 0.180 |
Why?
|
| Phenylpropionates | 2 | 2010 | 17 | 0.170 |
Why?
|
| Trifluoroacetic Acid | 1 | 2019 | 2 | 0.170 |
Why?
|
| Hypoxia | 3 | 2018 | 476 | 0.170 |
Why?
|
| Thyroid Carcinoma, Anaplastic | 4 | 2015 | 273 | 0.170 |
Why?
|
| Dihydroxyacetone | 1 | 2019 | 1 | 0.170 |
Why?
|
| Pericardial Effusion | 1 | 2020 | 125 | 0.170 |
Why?
|
| Optical Imaging | 2 | 2018 | 158 | 0.160 |
Why?
|
| Osteoradionecrosis | 1 | 2020 | 128 | 0.160 |
Why?
|
| Mandible | 1 | 2020 | 190 | 0.160 |
Why?
|
| Urea | 1 | 2020 | 304 | 0.160 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 2 | 2010 | 154 | 0.160 |
Why?
|
| Area Under Curve | 1 | 2020 | 729 | 0.160 |
Why?
|
| Glycolysis | 2 | 2019 | 534 | 0.160 |
Why?
|
| Ovarian Neoplasms | 4 | 2017 | 4797 | 0.160 |
Why?
|
| Fluorine Radioisotopes | 1 | 2019 | 139 | 0.150 |
Why?
|
| Neovascularization, Pathologic | 5 | 2018 | 1596 | 0.150 |
Why?
|
| Fluorescence | 1 | 2018 | 199 | 0.150 |
Why?
|
| Molecular Imaging | 3 | 2017 | 186 | 0.150 |
Why?
|
| Ablation Techniques | 1 | 2019 | 150 | 0.150 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2010 | 399 | 0.150 |
Why?
|
| Models, Animal | 2 | 2012 | 673 | 0.150 |
Why?
|
| Carcinoma | 3 | 2015 | 2624 | 0.140 |
Why?
|
| K562 Cells | 2 | 2016 | 345 | 0.140 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2015 | 1266 | 0.140 |
Why?
|
| Mice, SCID | 8 | 2019 | 1851 | 0.140 |
Why?
|
| Analog-Digital Conversion | 1 | 2015 | 5 | 0.130 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2016 | 57 | 0.130 |
Why?
|
| Radiation Injuries | 2 | 2020 | 1472 | 0.130 |
Why?
|
| Microvessels | 2 | 2015 | 143 | 0.130 |
Why?
|
| Phosphoramide Mustards | 1 | 2015 | 37 | 0.130 |
Why?
|
| Enzymes | 1 | 2015 | 72 | 0.130 |
Why?
|
| Glutaminase | 1 | 2016 | 71 | 0.130 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 2014 | 17 | 0.120 |
Why?
|
| Nitroimidazoles | 1 | 2015 | 107 | 0.120 |
Why?
|
| Laser Therapy | 3 | 2004 | 465 | 0.120 |
Why?
|
| Medical Oncology | 1 | 2023 | 1462 | 0.120 |
Why?
|
| Indoles | 2 | 2013 | 1034 | 0.120 |
Why?
|
| Heterografts | 2 | 2014 | 745 | 0.120 |
Why?
|
| Motion | 2 | 2018 | 200 | 0.120 |
Why?
|
| Cell Count | 1 | 2016 | 524 | 0.120 |
Why?
|
| Perfusion | 1 | 2016 | 285 | 0.120 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 311 | 0.120 |
Why?
|
| Radionuclide Imaging | 1 | 2015 | 656 | 0.120 |
Why?
|
| Lung Neoplasms | 4 | 2020 | 12035 | 0.120 |
Why?
|
| Prodrugs | 1 | 2015 | 226 | 0.120 |
Why?
|
| Capillary Permeability | 2 | 2018 | 116 | 0.120 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 488 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2015 | 3671 | 0.110 |
Why?
|
| Butadienes | 1 | 2013 | 36 | 0.110 |
Why?
|
| Medulloblastoma | 1 | 2019 | 588 | 0.110 |
Why?
|
| Dogs | 5 | 2008 | 1168 | 0.110 |
Why?
|
| Positron-Emission Tomography | 5 | 2014 | 2197 | 0.110 |
Why?
|
| Receptors, Androgen | 1 | 2018 | 912 | 0.110 |
Why?
|
| Pericytes | 1 | 2013 | 91 | 0.110 |
Why?
|
| Antineoplastic Agents | 5 | 2023 | 14647 | 0.110 |
Why?
|
| Radiotherapy | 2 | 2018 | 1862 | 0.100 |
Why?
|
| Gated Blood-Pool Imaging | 1 | 2012 | 19 | 0.100 |
Why?
|
| Coordination Complexes | 1 | 2012 | 17 | 0.100 |
Why?
|
| Glioma | 3 | 2019 | 1988 | 0.100 |
Why?
|
| Prostatic Hyperplasia | 1 | 2013 | 221 | 0.100 |
Why?
|
| Deoxyglucose | 1 | 2012 | 124 | 0.100 |
Why?
|
| Kidney | 1 | 2021 | 2263 | 0.100 |
Why?
|
| Radiation Tolerance | 2 | 2015 | 636 | 0.100 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2023 | 5418 | 0.100 |
Why?
|
| Mitochondria | 1 | 2018 | 1313 | 0.100 |
Why?
|
| Bevacizumab | 1 | 2015 | 957 | 0.100 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2017 | 1260 | 0.090 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 879 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2017 | 5606 | 0.090 |
Why?
|
| Myocardial Infarction | 2 | 2010 | 1297 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2013 | 7794 | 0.090 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2011 | 61 | 0.090 |
Why?
|
| Silicon Dioxide | 2 | 2022 | 53 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2011 | 249 | 0.090 |
Why?
|
| Pyrimidines | 2 | 2017 | 3663 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 2398 | 0.090 |
Why?
|
| Nanoparticles | 3 | 2010 | 585 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2014 | 1668 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 1433 | 0.090 |
Why?
|
| Wilms Tumor | 1 | 2013 | 302 | 0.090 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2010 | 30 | 0.090 |
Why?
|
| Gonanes | 1 | 2010 | 52 | 0.090 |
Why?
|
| RNA, Long Noncoding | 1 | 2016 | 619 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2016 | 2469 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 969 | 0.090 |
Why?
|
| Tissue Culture Techniques | 1 | 2010 | 112 | 0.090 |
Why?
|
| Ferrosoferric Oxide | 1 | 2010 | 39 | 0.090 |
Why?
|
| Time Factors | 4 | 2020 | 13129 | 0.090 |
Why?
|
| Tumor Burden | 5 | 2020 | 2035 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2016 | 5783 | 0.080 |
Why?
|
| T-Lymphocytes | 2 | 2014 | 3946 | 0.080 |
Why?
|
| Rats | 6 | 2018 | 6641 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 269 | 0.080 |
Why?
|
| Pyrroles | 1 | 2013 | 592 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 1012 | 0.080 |
Why?
|
| Coronary Vessels | 1 | 2013 | 639 | 0.080 |
Why?
|
| Fluorescent Dyes | 2 | 2008 | 468 | 0.080 |
Why?
|
| Myocardium | 2 | 2011 | 1244 | 0.080 |
Why?
|
| Antigens, CD34 | 1 | 2010 | 643 | 0.080 |
Why?
|
| Skin Aging | 1 | 2008 | 24 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 3 | 2018 | 5248 | 0.080 |
Why?
|
| Nitriles | 1 | 2013 | 945 | 0.080 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2014 | 1135 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2017 | 1929 | 0.070 |
Why?
|
| Ischemia | 1 | 2011 | 407 | 0.070 |
Why?
|
| Bone Marrow | 1 | 2015 | 2446 | 0.070 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2018 | 2453 | 0.070 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2007 | 143 | 0.070 |
Why?
|
| Cisplatin | 2 | 2023 | 2501 | 0.070 |
Why?
|
| Apoptosis | 5 | 2019 | 7839 | 0.070 |
Why?
|
| Polyglutamic Acid | 1 | 2007 | 49 | 0.070 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2010 | 381 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2020 | 5570 | 0.070 |
Why?
|
| Injections, Subcutaneous | 1 | 2007 | 344 | 0.070 |
Why?
|
| Fibrosarcoma | 1 | 2007 | 142 | 0.070 |
Why?
|
| Models, Statistical | 2 | 2011 | 1188 | 0.070 |
Why?
|
| Leukemia | 1 | 2015 | 1721 | 0.070 |
Why?
|
| Female | 22 | 2021 | 149251 | 0.070 |
Why?
|
| Glioblastoma | 3 | 2018 | 1781 | 0.070 |
Why?
|
| Proteins | 2 | 2012 | 2058 | 0.070 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2008 | 363 | 0.070 |
Why?
|
| Genes, p53 | 1 | 2011 | 1146 | 0.070 |
Why?
|
| Temperature | 2 | 2005 | 540 | 0.070 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2007 | 173 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2021 | 9097 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 665 | 0.070 |
Why?
|
| Lymphoma | 1 | 2014 | 1513 | 0.070 |
Why?
|
| Quinazolines | 1 | 2011 | 953 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2011 | 1485 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2018 | 2174 | 0.060 |
Why?
|
| Diagnostic Imaging | 2 | 2011 | 1177 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2007 | 490 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2011 | 1198 | 0.060 |
Why?
|
| Stromal Cells | 1 | 2009 | 834 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2021 | 16630 | 0.060 |
Why?
|
| Piperidines | 1 | 2011 | 1091 | 0.060 |
Why?
|
| Glucose | 2 | 2023 | 1246 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 4 | 2019 | 5805 | 0.060 |
Why?
|
| Spinal Cord | 1 | 2008 | 724 | 0.060 |
Why?
|
| Cell Hypoxia | 3 | 2011 | 353 | 0.060 |
Why?
|
| Bone Neoplasms | 2 | 2008 | 2672 | 0.060 |
Why?
|
| Linear Models | 1 | 2008 | 1099 | 0.060 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2007 | 318 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 7238 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 3018 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2010 | 707 | 0.060 |
Why?
|
| Organ Size | 3 | 2013 | 725 | 0.060 |
Why?
|
| Radiation, Ionizing | 2 | 2015 | 191 | 0.060 |
Why?
|
| Water | 2 | 2007 | 384 | 0.060 |
Why?
|
| Laser Coagulation | 1 | 2005 | 141 | 0.060 |
Why?
|
| Abdomen | 1 | 2005 | 348 | 0.060 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2008 | 621 | 0.060 |
Why?
|
| Biomarkers | 1 | 2015 | 5098 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2014 | 1904 | 0.060 |
Why?
|
| Infrared Rays | 1 | 2003 | 62 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2008 | 2330 | 0.060 |
Why?
|
| Nanotechnology | 3 | 2010 | 137 | 0.050 |
Why?
|
| Cell Proliferation | 4 | 2019 | 7300 | 0.050 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2006 | 609 | 0.050 |
Why?
|
| Diet, High-Fat | 1 | 2024 | 254 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2009 | 1423 | 0.050 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2023 | 118 | 0.050 |
Why?
|
| Skin | 1 | 2008 | 1283 | 0.050 |
Why?
|
| Neoplasms, Experimental | 3 | 2015 | 790 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2011 | 2383 | 0.050 |
Why?
|
| Trimethylsilyl Compounds | 1 | 2001 | 4 | 0.050 |
Why?
|
| Silanes | 1 | 2001 | 7 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 4362 | 0.050 |
Why?
|
| Radiography | 3 | 2015 | 1994 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2024 | 448 | 0.050 |
Why?
|
| Brachytherapy | 1 | 2008 | 1005 | 0.050 |
Why?
|
| Cell Survival | 3 | 2014 | 3074 | 0.050 |
Why?
|
| Necrosis | 2 | 2018 | 604 | 0.050 |
Why?
|
| Liposomes | 2 | 2016 | 709 | 0.050 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2004 | 382 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 4819 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2023 | 256 | 0.050 |
Why?
|
| Breast Neoplasms | 2 | 2021 | 16252 | 0.050 |
Why?
|
| Radio Waves | 1 | 2000 | 15 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2021 | 2105 | 0.050 |
Why?
|
| Biophysical Phenomena | 1 | 2000 | 117 | 0.040 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 2 | 2011 | 170 | 0.040 |
Why?
|
| Biophysics | 1 | 2000 | 117 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2011 | 449 | 0.040 |
Why?
|
| Fluorine | 1 | 2019 | 22 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2022 | 39817 | 0.040 |
Why?
|
| Protein Binding | 2 | 2018 | 3527 | 0.040 |
Why?
|
| Sarcoma | 1 | 2010 | 1839 | 0.040 |
Why?
|
| Signal Transduction | 4 | 2021 | 12212 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2006 | 1039 | 0.040 |
Why?
|
| Sus scrofa | 1 | 2019 | 165 | 0.040 |
Why?
|
| Immunohistochemistry | 4 | 2013 | 7832 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2014 | 1132 | 0.040 |
Why?
|
| Piperazines | 1 | 2007 | 2147 | 0.040 |
Why?
|
| Quality Control | 1 | 2000 | 467 | 0.040 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2018 | 44 | 0.040 |
Why?
|
| Permeability | 1 | 2018 | 161 | 0.040 |
Why?
|
| Rabbits | 1 | 2020 | 1077 | 0.040 |
Why?
|
| Manganese | 1 | 2018 | 65 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2022 | 655 | 0.040 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2018 | 77 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2020 | 991 | 0.040 |
Why?
|
| Micelles | 1 | 2018 | 39 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 703 | 0.040 |
Why?
|
| Phototherapy | 1 | 2018 | 83 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 1085 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2021 | 1966 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 2 | 2010 | 350 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2007 | 4971 | 0.040 |
Why?
|
| Tumor Stem Cell Assay | 2 | 2009 | 233 | 0.040 |
Why?
|
| Stroke Volume | 2 | 2010 | 552 | 0.040 |
Why?
|
| Biological Transport | 1 | 2018 | 645 | 0.040 |
Why?
|
| Metabolomics | 1 | 2021 | 506 | 0.040 |
Why?
|
| Alleles | 2 | 2016 | 2600 | 0.040 |
Why?
|
| Machine Learning | 1 | 2020 | 362 | 0.040 |
Why?
|
| Platinum Compounds | 1 | 2017 | 129 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 342 | 0.030 |
Why?
|
| Glutamine | 1 | 2018 | 328 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 910 | 0.030 |
Why?
|
| Transplantation, Heterologous | 2 | 2011 | 1085 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2007 | 3082 | 0.030 |
Why?
|
| Polymers | 1 | 2018 | 223 | 0.030 |
Why?
|
| Chemoradiotherapy | 2 | 2018 | 2030 | 0.030 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2007 | 1913 | 0.030 |
Why?
|
| Rats, Nude | 1 | 2015 | 28 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2017 | 1841 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2020 | 1046 | 0.030 |
Why?
|
| Indazoles | 1 | 2017 | 310 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2016 | 125 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2020 | 13398 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2016 | 355 | 0.030 |
Why?
|
| Iron | 1 | 2018 | 381 | 0.030 |
Why?
|
| Receptor Activity-Modifying Protein 3 | 1 | 2014 | 19 | 0.030 |
Why?
|
| Receptors, Calcitonin | 1 | 2014 | 28 | 0.030 |
Why?
|
| Wound Healing | 1 | 2020 | 761 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 2218 | 0.030 |
Why?
|
| Tumor Protein p73 | 1 | 2014 | 114 | 0.030 |
Why?
|
| Random Allocation | 2 | 2006 | 745 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 3362 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2014 | 38 | 0.030 |
Why?
|
| Fluoresceins | 1 | 2014 | 74 | 0.030 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2018 | 469 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2010 | 3644 | 0.030 |
Why?
|
| Oxygen | 1 | 2018 | 795 | 0.030 |
Why?
|
| Electroporation | 1 | 2014 | 127 | 0.030 |
Why?
|
| Thymus Gland | 1 | 2014 | 312 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2008 | 2255 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 2864 | 0.030 |
Why?
|
| Logistic Models | 1 | 2020 | 3462 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2013 | 206 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2015 | 582 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2016 | 613 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2013 | 94 | 0.030 |
Why?
|
| Chromatography, Thin Layer | 1 | 2012 | 70 | 0.030 |
Why?
|
| Indium Radioisotopes | 1 | 2012 | 64 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2014 | 751 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2011 | 4983 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 4964 | 0.020 |
Why?
|
| Benzamides | 2 | 2007 | 1881 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 436 | 0.020 |
Why?
|
| Carcinoma, Papillary | 1 | 2015 | 580 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2013 | 5832 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2009 | 1586 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 5183 | 0.020 |
Why?
|
| In Vitro Techniques | 2 | 2004 | 1741 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2013 | 384 | 0.020 |
Why?
|
| Antigens, CD19 | 1 | 2014 | 583 | 0.020 |
Why?
|
| Photoelectron Spectroscopy | 1 | 2010 | 6 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2011 | 387 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 30 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 337 | 0.020 |
Why?
|
| Porosity | 1 | 2010 | 56 | 0.020 |
Why?
|
| Inovirus | 1 | 2010 | 3 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2018 | 2103 | 0.020 |
Why?
|
| Spheroids, Cellular | 1 | 2011 | 217 | 0.020 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2010 | 63 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2011 | 360 | 0.020 |
Why?
|
| Chemokine CXCL10 | 1 | 2010 | 106 | 0.020 |
Why?
|
| Luminescence | 1 | 2009 | 45 | 0.020 |
Why?
|
| Weight-Bearing | 1 | 2010 | 64 | 0.020 |
Why?
|
| Introns | 1 | 2011 | 461 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2010 | 87 | 0.020 |
Why?
|
| Particle Size | 1 | 2009 | 187 | 0.020 |
Why?
|
| Surface Properties | 1 | 2009 | 188 | 0.020 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2010 | 211 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2011 | 909 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2011 | 444 | 0.020 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2020 | 2167 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2011 | 349 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 2010 | 256 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2014 | 1229 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2017 | 33911 | 0.020 |
Why?
|
| Glass | 1 | 2008 | 33 | 0.020 |
Why?
|
| Nitrates | 1 | 2008 | 46 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 760 | 0.020 |
Why?
|
| Cobalt | 1 | 2008 | 57 | 0.020 |
Why?
|
| Acrylates | 1 | 2008 | 33 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2014 | 1653 | 0.020 |
Why?
|
| Whole-Body Irradiation | 1 | 2009 | 324 | 0.020 |
Why?
|
| Drug Carriers | 1 | 2009 | 337 | 0.020 |
Why?
|
| Cardiotoxins | 1 | 2007 | 16 | 0.020 |
Why?
|
| Mathematical Computing | 1 | 2007 | 23 | 0.020 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2008 | 82 | 0.020 |
Why?
|
| DNA Damage | 1 | 2015 | 1988 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 3078 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 1143 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 782 | 0.020 |
Why?
|
| Solubility | 1 | 2007 | 251 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 2469 | 0.020 |
Why?
|
| Regeneration | 1 | 2009 | 286 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2007 | 727 | 0.020 |
Why?
|
| Terbutaline | 1 | 2006 | 30 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2009 | 1209 | 0.020 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2006 | 68 | 0.020 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2006 | 75 | 0.020 |
Why?
|
| Disease Progression | 1 | 2018 | 6904 | 0.020 |
Why?
|
| Astrocytes | 1 | 2010 | 408 | 0.020 |
Why?
|
| Isoproterenol | 1 | 2006 | 135 | 0.020 |
Why?
|
| Peptides | 1 | 2012 | 1528 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2009 | 570 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2007 | 568 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 1534 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 6489 | 0.020 |
Why?
|
| Body Water | 1 | 2005 | 125 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2008 | 366 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2008 | 588 | 0.020 |
Why?
|
| Body Weight | 1 | 2010 | 1336 | 0.020 |
Why?
|
| Skin Diseases | 1 | 2008 | 366 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2006 | 637 | 0.010 |
Why?
|
| Venereal Tumors, Veterinary | 1 | 2004 | 11 | 0.010 |
Why?
|
| Phthalazines | 1 | 2006 | 263 | 0.010 |
Why?
|
| Computer Terminals | 1 | 2004 | 12 | 0.010 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2007 | 557 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 2495 | 0.010 |
Why?
|
| Silicon | 1 | 2003 | 48 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 3648 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 5516 | 0.010 |
Why?
|
| Imatinib Mesylate | 1 | 2007 | 1690 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 813 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 3471 | 0.010 |
Why?
|
| Cholesterol | 1 | 2006 | 681 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2010 | 3147 | 0.010 |
Why?
|
| Feedback | 1 | 2004 | 227 | 0.010 |
Why?
|
| Muscles | 1 | 2004 | 461 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 3416 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 5103 | 0.010 |
Why?
|
| Cell Line | 1 | 2010 | 5432 | 0.010 |
Why?
|
| Cattle | 1 | 2004 | 845 | 0.010 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2007 | 1144 | 0.010 |
Why?
|
| Respiration | 1 | 2004 | 465 | 0.010 |
Why?
|
| Radiographic Image Enhancement | 1 | 2004 | 410 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2007 | 735 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 22167 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 5063 | 0.010 |
Why?
|
| Movement | 1 | 2004 | 563 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2006 | 1887 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6275 | 0.010 |
Why?
|
| Biopsy | 1 | 2008 | 3543 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 10369 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2004 | 914 | 0.010 |
Why?
|
| Swine | 1 | 2004 | 1609 | 0.010 |
Why?
|
| Pyridines | 1 | 2006 | 1311 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2009 | 4188 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 9052 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 12545 | 0.010 |
Why?
|
| Heart Failure | 1 | 2010 | 2380 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 73494 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 81964 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 90447 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 7981 | 0.010 |
Why?
|